Wu, Douglas C.
Lambowitz, Alan M.
Article History
Received: 23 May 2017
Accepted: 20 July 2017
First Online: 21 August 2017
Change Date: 1 March 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Competing Interests
: Thermostable group II intron reverse transcriptase (TGIRT) enzymes and methods for their use are the subject of patents and patent applications that have been licensed by the University of Texas and East Tennessee State University to InGex, LLC. A.M.L. and the University of Texas are minority equity holders in InGex, LLC, and A.M.L. and some present and former Lambowitz laboratory members receive royalty payments from the sale of TGIRT enzymes and kits and from the licensing of intellectual property.